Lee Albacker

25PUBLICATIONS
160CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do

|Sep 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab.

Douglas I Lin, Julia C F Quintanilha, Natalie Danziger

|Oct 06, 2023
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.

Nicholas C Turner, A Douglas Laird, Melinda L Telli

|Jan 09, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.

Emily L Hoskins, Eric Samorodnitsky, Michele R Wing

|Jan 05, 2023
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma.

Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins

Pageof 5